Advertisements
Feeds:
Posts
Comments

Archive for the ‘LPBI Group, e-Scientific Media, DFP, R&D-M3DP, R&D-Drug Discovery, US Patents: SOPs and Team Management’ Category


The #WMIF19 Influencers via ‘s  Hashtags http://bit.ly/WMIF19 – By Mentions and By Tweets Ranked #4: @pharma_BI and #2: @AVIVA1950, respectively. Ranked #3 via NodeXL Betweenness Centrality http://bit.ly/2KB6cPN

 

Ranked #3 via NodeXL Betweenness Centrality http://bit.ly/2KB6cPN

@phsinnovation
@evankirstel
@aviva1950

New Rankings

#4 on Mentions: @pharma_BI and

#2 on number of Tweets: @AVIVA1950

via

‘s  Hashtags http://bit.ly/WMIF19

 

 

Third Place in Top 10 Influencers 

Ranked #3 via NodeXL Betweenness Centrality http://bit.ly/2KB6cPN

@phsinnovation
@evankirstel

 Tweets, N=152

 

SOURCE

https://nodexlgraphgallery.org/Pages/Graph.aspx?graphID=193125

 

 

line separator end

 

 

03/10 –

03/16

03/17 –

03/23

03/24 –

03/30

03/31 –

04/06

04/07 –

04/13

Likes

9

4

29

27

123

Followers

358

360

363

383

391

Friends

1.4K

1.4K

1.5K

1.5K

1.5K

Mention Reach

1.7K

395

1.4K

33.6K

23.7K

Mentions

10

3

16

3

14

Replies

0

0

0

0

0

Retweet Reach

6.4K

784

2.1K

73.6K

129.9K

Retweets

7

2

12

20

66

Tweets

12

8

56

44

154

 

 

 

AVIVA1950

Twitter

 

 

 

 

 

04/07 – 04/13

Δ 7d

Last 5w

 

Likes

123

+96

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Followers

391

+8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Friends

1.5K

+7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mention Reach

23.7K

-9.9K

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mentions

14

+11

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Replies

0

+0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Retweet Reach

129.9K

+56.3K

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Retweets

66

+46

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tweets

154

+110

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SOURCE

From: SumAll <sumall@sumall.com>

Date: Sunday, April 14, 2019 at 5:05 PM

To: “<Aviva Lev-Ari>”, <PhD>, Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>

Subject: My Weekly Digest: Week of Apr 7, 2019

 

Top 3 Ranked by Betweenness Centrality in Top 10 Influencers   Twitter Analytics by NodeXL for #WMIF19 by @PHSInnovation  at World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 8-10, 2019

https://pharmaceuticalintelligence.com/2019/04/11/top-3-ranked-by-betweenness-centrality-in-top-10-influencers-wmif19-phsinnovation-evankirstel-aviva1950-tweeter-analytics-by-nodexl-http-bit-ly-2kb6cpn-for-wmif19-by-phs/

 

Tweets, ReTweets and Likes by @AVIVA1950 and by @pharma_BIusing @PHSInnovation and #WMIF19 during Day One, Two and Three of World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 8-10, 2019

https://pharmaceuticalintelligence.com/2019/04/11/tweets-retweets-and-likes-by-aviva1950-and-by-pharma_bi-using-phsinnovation-and-wmif19-during-day-one-two-and-three-of-world-medical-innovation-forum-artificial-intelligence-boston-ma-us/

 

LIVE Day One – World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Westin Copley Place, Boston, MA USA, Monday, April 8, 2019

https://pharmaceuticalintelligence.com/2019/04/08/live-day-one-world-medical-innovation-forum-artificial-intelligence-westin-copley-place-boston-ma-usa-monday-april-8-2019/

 

LIVE Day Two – World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 9, 2019

https://pharmaceuticalintelligence.com/2019/04/09/live-day-two-world-medical-innovation-forum-artificial-intelligence-boston-ma-usa-monday-april-9-2019/

 

LIVE Day Three – World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 10, 2019

https://pharmaceuticalintelligence.com/2019/04/10/live-day-three-world-medical-innovation-forum-artificial-intelligence-boston-ma-usa-monday-april-10-2019/

 

 

Advertisements

Read Full Post »


Top 3 Ranked by Betweenness Centrality in Top 10 Influencers   Twitter Analytics by NodeXL for #WMIF19 by @PHSInnovation  at World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 8-10, 2019

 

www.worldmedicalinnovation.org

 

‘s Hashtags  – Twitter Analytics published for http://bit.ly/WMIF19 

  • [Top 10 by Mentions – @pharma_BI = 4 with 181 mentions]  
  • [Top 10 by Tweets @AVIVA1950 = 2 with 229 Tweets (N = 152 Direct messages)]
 Pinned Tweet

⚡️As World Forum comes to a close, here are TOP via ‘s Hashtags 🙏 to organizers for a stellar event & to all on for a robust conversation! 👏

 

Third Place in Top 10 Influencers 

  

 Tweets, N=152

 

SOURCE

https://nodexlgraphgallery.org/Pages/Graph.aspx?graphID=193125

 

#WMIF19_2019-04-09_09-37-27.xlsx

View an interactive version of this graph (experimental)

From:

Connected Action NodeXL-Reports

Uploaded on:

April 09, 2019

Short Description:

 

#WMIF19 via NodeXL http://bit.ly/2KB6cPN

@phsinnovation
@evankirstel
@aviva1950
@partnersnews
@beyondverbal
@dme_jun
@seemacms
@bwhihub
@massgovernor
@doylet

Top hashtags:
#wmif19
#ai
#healthcare
#artificialintelligence
#boston
#innovation
#wmif
#aiinpharma

Description:

 

Description

The graph represents a network of 731 Twitter users whose recent tweets contained “#WMIF19”, or who were replied to or mentioned in those tweets, taken from a data set limited to a maximum of 18,000 tweets. The network was obtained from Twitter on Tuesday, 09 April 2019 at 16:40 UTC.

The tweets in the network were tweeted over the 9-day, 18-hour, 32-minute period from Saturday, 30 March 2019 at 22:04 UTC to Tuesday, 09 April 2019 at 16:37 UTC.

Additional tweets that were mentioned in this data set were also collected from prior time periods. These tweets may expand the complete time period of the data.

There is an edge for each “replies-to” relationship in a tweet, an edge for each “mentions” relationship in a tweet, and a self-loop edge for each tweet that is not a “replies-to” or “mentions”.

The graph is directed.

The graph’s vertices were grouped by cluster using the Clauset-Newman-Moore cluster algorithm.

The graph was laid out using the Harel-Koren Fast Multiscale layout algorithm.

 

Highlighted in RED rankings for

@AVIVA1950

@pharma_BI

http://pharmaceuticalintelligence.com 

 

Top Influencers: Top 10 Vertices, Ranked by Betweenness Centrality

 

@phsinnovation
Smart Tweet

 

@evankirstel
Smart Tweet

 

@aviva1950
Smart Tweet

 

@partnersnews
Smart Tweet

 

@beyondverbal
Smart Tweet

 

@dme_jun
Smart Tweet

 

@seemacms
Smart Tweet

 

@bwhihub
Smart Tweet

 

@massgovernor
Smart Tweet

 

@doylet

 

Top URLs in Tweet in G3:

 

[3] https://www.fitzroyhealth.com/wmif
[2] https://worldmedicalinnovation.org/agenda/

[2] https://twitter.com/aviva1950/status/1115292614402695169 

[1] https://www.fda.gov/downloads/MedicalDevices/DigitalHealth/SoftwareasaMedicalDevice/UCM635052.pdf
[1] https://www.youtube.com/watch?v=AGhC864Wh-0

[1] https://www.youtube.com/watch?v=_wIO2EAM1xw

[1] https://twitter.com/happysylvie/status/1115639128455041025
[1] https://twitter.com/BayerUS/status/1114211171517784064
[1] https://twitter.com/BayerUS/status/1115245439173967872
[1] https://twitter.com/BayerPharma/status/1115259254003458049

 

Top Domains in Tweet in G2:

 

[26] twitter.com
[10] bwhclinicalandresearchnews.org
[6] worldmedicalinnovation.org
[5] linkedin.com
[2] lnkd.in
[1] connectwithpartners.org
[1] healthdatamanagement.com
[1] pharmaceuticalintelligence.com 
[1] youtube.com
[1] npr.org

 

Top Words in Tweet in G2:

 

[415] #wmif19
[236] phsinnovation
[163] #ai
[124] ai
[93] data
[91] dr
[82] care
[81] aviva1950 
[80] pharma_bi 
[78] healthcare

 

Top Mentioned in Entire Graph:

 

@phsinnovation
Follow Smart Tweet

 

@partnersnews
Follow Smart Tweet

 

@aviva1950
Follow Smart Tweet

 

@seemacms
Follow Smart Tweet

 

@pharma_bi
Follow Smart Tweet

 

@nvidia
Follow Smart Tweet

 

@brighamwomens
Follow Smart Tweet

 

@gehealthcare
Follow Smart Tweet

 

@massgovernor
Follow Smart Tweet

 

@evankirstel
Follow Smart Tweet

 

 

 

Top Mentioned in G1:

 

@phsinnovation
Follow Smart Tweet

 

@partnersnews
Follow Smart Tweet

 

@gehealthcare
Follow Smart Tweet

 

@nvidia
Follow Smart Tweet

 

@aviva1950
Follow Smart Tweet

 

@seemacms
Follow Smart Tweet

 

@kieranmurphyceo
Follow Smart Tweet

 

@constancelehman
Follow Smart Tweet

 

@terribresenham
Follow Smart Tweet

 

@bayer
Follow Smart Tweet

 

Top Mentioned in G2:

 

@phsinnovation
Follow Smart Tweet

 

@aviva1950
Follow Smart Tweet

 

@brighamwomens
Follow Smart Tweet

 

@partnersnews
Follow Smart Tweet

 

@pharma_bi
Follow Smart Tweet

 

@massgovernor
Follow Smart Tweet

 

@massgeneralnews
Follow Smart Tweet

 

@bwhihub
Follow Smart Tweet

 

@chencao
Follow Smart Tweet

 

Top Mentioned in G5:

 

@evankirstel
Follow Smart Tweet

 

@phsinnovation
Follow Smart Tweet

 

@irmaraste
Follow Smart Tweet

 

@evirahealth
Follow Smart Tweet

 

@philips
Follow Smart Tweet

 

@aviva1950
Follow Smart Tweet

 

@pharma_bi
Follow Smart Tweet

 

@health_xl
Follow Smart Tweet

 

@nvidia
Follow Smart Tweet

 

@edvaldez8888
Follow Smart Tweet

 

 

Top Domains in Tweet in G2:

 

[26] twitter.com
[10] bwhclinicalandresearchnews.org
[6] worldmedicalinnovation.org
[5] linkedin.com
[2] lnkd.in
[1] connectwithpartners.org
[1] healthdatamanagement.com
[1] pharmaceuticalintelligence.com 
[1] youtube.com
[1] npr.org

 

Top Words in Tweet in G2:

[415] #wmif19
[236] phsinnovation
[163] #ai
[124] ai
[93] data
[91] dr
[82] care
[81] aviva1950 
[80] pharma_bi 
[78] healthcare

 

Top Word Pairs in Tweet in Entire Graph:

 

[131] phsinnovation,#wmif19
[129] medical,innovation
[105] world,medical
[102] pharma_bi,aviva1950 
[101] innovation,forum
[59] #wmif19,phsinnovation
[55] looking,forward
[52] first,look
[51] jensen,huang
[47] #wmif19,evankristel

 

Top Word Pairs in Tweet in G1:

 

[36] phsinnovation,#wmif19
[23] innovation,forum
[22] world,medical
[22] medical,innovation
[20] #wmif19,phsinnovation
[20] nvidia,ceo
[19] jensen,huang
[18] pharma_bi,aviva1950 
[18] #wmif,#wmif19
[17] looking,forward

 

Top Word Pairs in Tweet in G2:

 

[77] pharma_bi,aviva1950 
[72] phsinnovation,#wmif19
[50] medical,innovation
[38] #wmif19,evankristel
[38] evankristel,pharma_bi 
[31] first,look
[30] today,s
[25] world,medical
[25] innovation,forum
[24] aviva1950,phsinnovation 

 

 

Top Replied-To in Entire Graph:

 

@phsinnovation
Follow Smart Tweet

 

@pharma_bi
Follow Smart Tweet

 

@constancelehman
Follow Smart Tweet

 

@massgovernor
Follow Smart Tweet

 

@seemacms
Follow Smart Tweet

 

Top Replied-To in G2:

 

@phsinnovation
Follow Smart Tweet

 

@pharma_bi
Follow Smart Tweet

 

@massgovernor
Follow Smart Tweet

 

@brighamwomens
Follow Smart Tweet

 

@masseyeandear
Follow Smart Tweet
@landmaad
Follow Smart Tweet

 

@peterrchai
Follow Smart Tweet

 

@gilpress
Follow Smart Tweet

 

@nancyatheart
Follow Smart Tweet

 

@brighamresearch
Follow Smart Tweet

 

Download the Graph Data as a NodeXL Workbook

Download the Graph Data as GraphML

Download the NodeXL Options Used to Create the Graph

 

Read Full Post »


Tips on 280 Character Tweets on Twitter.com

 

The FIT members @LPBI Group are edified by the following advice and tips on TWEETING

 

From: Gail Thornton <gailsthornton@yahoo.com>

Reply-To: Gail Thornton <gailsthornton@yahoo.com>

Date: Saturday, March 2, 2019 at 5:33 PM

To: Rick Mandahl <rmandahl@gmail.com>, Amnon Danzig <amnon.danzig@gmail.com>, Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>

Subject: Re: In 280 Characters

Aviva:

Please let me offer some recommendations, suggestions and advice on how to compose tweets moving forward. These tips are a departure for how you currently compose and post tweets.

You need to find businesses, universities, research centers, who have a large number of followers (upwards of 500,000) and target them with your tweets.

Keep Tweets conversational.   Avoid business jargon when possible.

Think about how your content will be consumed by your followers. Would they want to retweet it or pass it along to others? Incorporate humor, inspiration and newsworthy content to draw followers in.

Twitter is particularly powerful at driving “amplification” for brand messages–retweets that share your message. In fact, 78% of user engagement with a brand’s Tweets is in the form of Retweets, This is essential in getting more people to read your tweets.

Tweets that contained more adverbs and verbs have a higher click-through rate than tweets with more nouns and adjectives. So the general rule that action words make for stronger, more compelling writing is also true for Tweets.

SUPER IMPORTANT: 

Consider creating a hashtag that is short, recognizable by followers, and allows them to easily follow along. If you’re using an existing hashtag, ensure you’re adding value to the conversation. The volume of hashtags is important as well: one or two hashtags can get you up to two times more engagement than tweets without hashtags (not 8-9-10), according to a study by Buddy Media/Salesforce.

There is usually a spike in retweets among those in the 71-100 character range—the “medium” length tweets column in this chart.   

 

Tweets with images received 18% more click-throughs, 89% more favorites, and 150% more retweets.

There is a 30% greater engagement rate when Tweets are published during the day (between 8AM-7PM). This makes sense if you consider the majority of news, store hours and activities happen during the day.

For example, a content calendar that you should adapt for LPBI. All businesses with Twitter accounts have a monthly content calendar that precisely and strategically lays out each day what you want to tweet. It is not a random act of tweeting that gets you noticed.

  • On Monday, you could launch a Twitter-only promotion for your followers. Tweet an online offer code or a secret word for customers to use when they visit your business.
  • On Tuesday, tweet a behind-the-scenes tour of your business. Highlight how your products are made or where they are sourced from.
  • On Wednesday: Create a regular series of Tweets that are informative or surprising such as tips.
  • On Thursday, retweet a few positive customer reviews. Or tweet some industry-related news your followers might find interesting.
  • Finally on Fridays, give customers a glimpse into your workplace culture. Tweet photos or Vine videos of your colleagues and employees hard at work or having fun.

Read Full Post »


Audio Podcasting @LPBI Group

Reporter: Aviva Lev-Ari, PhD, RN

 

On 3/9/2019 – Gail Thornton wrote:

The podcast idea is a good one if the content is unique to LPBI, which means podcasts need to created specifically for LBPI. Podcast ideas need to be created one per month, for example, and there  needs to be a calendar of them for the year with a specific person responsible for conducting it. 

Your aim is to get medical/scientific trade publications interested in retweeting your offerings — or interested in interviewing you or positioning LPBI and its key authors/writers as thought leaders on medical or scientific topics.

My idea: Anyone on the LPBI team can write a #ThoughtLeaderThursdays post for LinkedIn on a specific topic. These are creatively written brief articles on industry knowledge about a specific topic, current trends in science or insights into a scientific topic.

The posts are toughly 800-1,000 words. If anyone knows of a graphic designer, then a photo of the author can accompany the article along with a compelling graphic. Again, this is another way for others to share this post and for LPBI to develop a greater following of people

on social/digital media. On LinkedIn, type in #thoughtleaderthursdays and you’ll see examples. 

 

LinkedIn

LinkedIn

 

On 3/10/2019 – Dr. Williams wrote

Notes from book on Audio Podcasting

  1. Microphones -MOST important part is getting a good microphone
  2. Yeti by Blue Micorphone BEST
  3. Audiotechnia ATR BEST
  4. Logitech is OK but not best
  5. Test your microphones
  6. Test direction of microphone – above your mouth produces a nasal sound. Microphone at your throat produces too much bass
  7. Test microphone distance – SPEAK in NORMAL voice then adjust the GAIN later. Note: Skype does a good job auto-adjusting the gain so don’t worry while conducting interviews about Gain issues
  8. Get good headphones
  9. Eliminates background noise. Get good headphones like BEATS STUDIO which will detect any background noise during recording.

*** NOTE if doing a co-host podcast USE SKYPE

  1. Recording on Skype
  2. Record using either the Pamela or Call recorder Program. ALWAYS CHOOSE .wav format, never .mp3 format because . wav has higher quality
  3. EDITING -probably the SECOND MOST IMPORTANT PROCESS. There are three suggested audio editing software programs
  4. Audacity – this is a FREE program
  5. Adobe Audition – very good but $300
  6. If you have a Macintosh or Apple it comes with Garageband, a very good audio editing software
  7. Hosting
  8. If uploading a weekly show you will need a hosting site with at least 125 MB capacity per month
  9. If using WORDPRESS use the plugin Blubrry Power Press: lets you easily put in your audiopodcast
  10. Upload to itunes – it takes a week but they will give you a URL so you can put it on your blog site

 

  • On 3/9/2019 – Aviva posted

Top 10 CRISPR Podcasts Every Scientist (& Non-Scientist) by Synthego.com

Reporter: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2019/03/09/top-10-crispr-podcasts-every-scientist-non-scientist-by-synthego-com/

  • On 3/12/2015 – Dr. Williams posted

Podcast Review: Quiet Innovation Podcast on Obtaining $ for Your Startup

Reporter: Stephen J. Williams, Ph.D.

https://pharmaceuticalintelligence.com/2015/03/12/podcast-review-quiet-innovation-podcast-on-obtaining-for-your-startup/

 

  • On 1/25/2016 – Aviva posted

Launching LPBI’s, Fourth Line of Business (D): FIVE Podcast – Audio Series in BioMed

Curator: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2016/01/25/launching-lpbis-fourth-line-of-business-d-five-podcast-audio-series-in-biomed/

 

  • On 3/17/2016 – Aviva posted

CRISPR: A Podcast from Nature.com on Gene Editing

Reporter: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2016/03/17/crispr-a-podcast-from-nature-com-on-gene-editing/

 

We are inspired by

Browse podcasts, programs, news, features and in-depth coverage from Boston’s NPR news station.

https://www.wbur.org/programs

 

WBUR Programs And Podcasts

Morning Edition

Stories and commentaries that inform, challenge and occasionally…

On Point

Go behind the headlines: From the economy and…

Here & Now

NPR and WBUR’s live midday news program

Radio Boston

Provocative stories and authentic voices from around Boston

All Things Considered

News, interviews, commentaries, reviews and offbeat features

Only A Game

An award-winning weekly sports magazine hosted by veteran…

Modern Love

Modern Love features top actors performing true stories…

Dear Sugars

Radically empathic advice

Endless Thread

The front page of the Internet–also known as…

Last Seen

It remains the most valuable — and confounding…

Circle Round

Thoughtfully-selected folktales from around the world are adapted…

Kind World

Kind World is a show about compassion from…

Magic Pill

A daily dose of get-up-and-go

Edge of Fame

An exploration of the life that happens before,…

Season Ticket

Season Ticket is full of engaging talk, insightful…

Freak Out and Carry On

Freak Out and Carry On, WBUR’s politics and…

WBUR Sections

WBUR News

Local news coverage from WBUR

Cognoscenti

Thinking That Matters

CommonHealth

News and smart analysis on all things health

The ARTery

Arts | Culture | Boston

Bostonomix

The stories behind the Boston area’s innovation economy

Edify

Education: preschool to grad school

The Remembrance Project

Ordinary people who lived extraordinary lives

The Wild Life

Covering animal issues around the world

Open Source

An American conversation with global attitude

Special Projects

Recent special reports and series from WBUR’s newsroom

Read Full Post »


Top 10 CRISPR Podcasts Every Scientist (& Non-Scientist) by Synthego.com

Reporter: Aviva Lev-Ari, PhD, RN

 

 

  • On 3/12/2015 – Dr. Williams posted

Podcast Review: Quiet Innovation Podcast on Obtaining $ for Your Startup

Reporter: Stephen J. Williams, Ph.D.

https://pharmaceuticalintelligence.com/2015/03/12/podcast-review-quiet-innovation-podcast-on-obtaining-for-your-startup/

 

  • On 1/25/2016 – I posted

Launching LPBI’s, Fourth Line of Business (D): FIVE Podcast – Audio Series in BioMed

Curator: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2016/01/25/launching-lpbis-fourth-line-of-business-d-five-podcast-audio-series-in-biomed/

 

  • On 3/17/2016 – I posted

CRISPR: A Podcast from Nature.com on Gene Editing

Reporter: Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2016/03/17/crispr-a-podcast-from-nature-com-on-gene-editing/

 

 

Download eBook


CRISPR 101

CRISPR has ignited a revolution. Although it’s a relatively recent discovery in the history of biotechnology, CRISPR has quickly become a standard laboratory tool. This comprehensive CRISPR 101 eBook is designed to ease any scientist into the world of CRISPR by providing an overview of its fundamentals.

Download

Download eBook


CRISPR 101

CRISPR has ignited a revolution. Although it’s a relatively recent discovery in the history of biotechnology, CRISPR has quickly become a standard laboratory tool. This comprehensive CRISPR 101 eBook is designed to ease any scientist into the world of CRISPR by providing an overview of its fundamentals.

Download

SOURCE

https://www.synthego.com/blog/10-podcasts-every-crispr-scientist-will-love

Read Full Post »


Royalties in Kindle Unlimited and Kindle Owners’ Lending Library – A guide to publishing on Amazon

 

Royalties in Kindle Unlimited and Kindle Owners’ Lending Library

You’re eligible for royalty payment from Kindle Unlimited (KU, or Abonnement Kindle in France) and the Kindle Owners’ Lending Library (KOLL) for pages an individual customer reads in your book for the first time. A guide to publishing on Amazon

A customer can read your book as many times as they like, but we will only pay you for the number of pages read the first time the customer reads them. It may take months for customers to read pages in your book, but no matter how long it takes, we’ll still pay you once it happens. This is true even if your KDP Select enrollment period has expired, and you choose not to re-enroll.

Kindle Edition Normalized Page Count (KENPC v3.0)

To determine a book’s page count in a way that works across genres, devices, and display settings, we developed the Kindle Edition Normalized Page Count (KENPC). KENPC is calculated using standard formatting settings (font, line height, line spacing, etc.). We use KENPC to measure the number of pages customers read in your book, starting with the Start Reading Location (SRL) to the end of your book. Amazon typically sets SRL at chapter 1 so readers can start reading the core content of your book as soon as they open it. Non-text elements within books including images, charts and graphs will count toward a book’s KENPC.

KENPC v3.0
We released KENPC v3.0 to improve the way we measure how many pages of each book Kindle Unlimited and KOLL customers read. We’re constantly working to improve our programs and increase fairness of how we allocate the KDP Select Global Fund. These changes continue to improve the program and reward authors whose books are being borrowed and read the most by customers.

The KENPC v3.0 update applies uniformly to all KDP Select books and all versions of those books. Regardless of which version a customer may be reading, all future royalties will be paid using KENPC v3.0. If a customer previously borrowed your book and is still reading it, any new pages read will be based on KENPC v3.0.

Authors are able to earn a maximum of 3,000 Kindle Edition Normalized Pages (KENPs) read per title per customer. This means that each time your book is borrowed and read, you will receive credit for up to 3,000 pages. We believe this results in an equitable distribution of the KDP Select Global Fund.

Your book’s KENPC
You can see your book’s KENPC v3.0 listed on the “Promote and Advertise” page in your Bookshelf, and you can also see total pages read on your Sales Dashboard report. Because it’s based on default settings, KENPC v3.0 may vary from page counts listed on your Amazon detail page, which are derived from other sources.

KDP Select Global Fund
Our total payout from the KDP Select Global Fund will be unaffected by the transition to KENPC v3.0, and the amount you earn from the global fund will continue to be determined based on your share of total pages read by Kindle Unlimited (KU) and Kindle Owners’ Lending Library (KOLL) customers. The new KENPC version will be applied uniformly to all KDP Select books and used to measure all pages read.

 

Royalties

You’ll get one combined royalty payment for both KU and KOLL, paid according to the same payment schedule and payment method you selected for your other KDP sales.We review the size of the KDP Select Global Fund each month in order to make it compelling for authors to enroll their books in KDP Select. We announce the fund monthly in our community forum on kdp.amazon.com.The share of fund allocated to each country varies based on a number of factors, such as exchange rates, customer reading behavior, and local subscription pricing. Author earnings are then determined by their share of total pages read, up to a total of 3,000 pages per customer per title.

For example, here’s how we’d calculate royalty payout if $10 million in funds were available in a given month with 100 million total pages read (Note: Actual payouts vary and may be less; check your Prior Month’s Royalty Report to see your earnings):

  • Author with a 100 page bookthat was borrowed and read completely 100 times would earn $1,000 ($10 million multiplied by 10,000 pages for this author divided by 100,000,000 total pages).
  • Author of a 200 page bookthat was borrowed and read completely 100 times would earn $2,000 ($10 million multiplied by 20,000 pages for this author divided by 100,000,000 total pages).
  • Author of a 200 page bookthat was borrowed 100 times but only read halfway through on average would earn $1,000 ($10 million multiplied by 10,000 pages for this author divided by 100,000,000 total pages).

We always support our authors’ efforts to promote their books, but at the same time we work to prevent any manipulation of the Kindle platform.

We do not permit authors to offer, or participate in marketing that incentivizes Kindle Unlimited or Kindle Owners’ Lending Library customers to read their books in exchange for compensation of any kind. This includes payment (whether in the form of money or gift certificates), bonus content, entry to a contest or sweepstakes, discounts on future purchases, extra product, or other gifts.

Because we’re always looking to improve our authors’ experience, we have systems in place to monitor for potential manipulation.

 

Reporting

You can see your Kindle Edition Normalized Pages (KENP) Read in your Sales Dashboard report by marketplace and title. To see historical pages read, click “Generate Report” from your Sales Dashboard and go to the Orders Report tab.

If you’re enrolled in KDP Select, you will also see the following data on your reports:

Month-To-Date Unit Sales Report: The number of pages Kindle Unlimited or KOLL customers read of your books, under the “Kindle Edition Normalized Pages (KENP) Read” column.

Prior Months’ Royalties Report: For every title, there are five possible transaction types:

  • 35%:Amount a title earned under the 35% royalty option

  • 70%:Amount a title earned under the 70% royalty option

  • KDP Select Units:Amount every KDP Select-enrolled title earned monthly through Kindle Unlimited (KU) and the Kindle Owners’ Lending Library (KOLL). If a customer reads pages in your book for the first time through KU or KOLL, you will see a separate line item indicating the accumulated number of pages read under the column “Kindle Edition Normalized Pages (KENP) Read,” and the royalty earned through KU and KOLL under the “Royalty” column.

  • Free – Promotion:Free downloads due to Free promotion campaign(s) through KDP Select.

  • Free – Price Match:Free downloads due to competitor free price match.

 

SOURCE:  https://kdp.amazon.com/en_US/help/topic/G201541130

Read Full Post »


eScientific Publishing a Case in Point: Evolution of Platform Architecture Methodologies and of Intellectual Property Development (Content Creation by Curation) Business Model

Author: Aviva Lev- Ari, PhD, RN

 

Six demonstrations that justify the claims made in our 2019 VISION:

https://pharmaceuticalintelligence.com/vision/

  • Point #1: Top Author, Chief Scientific Officer, MD, FCAP – share in the Journal’s archive computed
  • Point #2: Top authors by e-Readers per article – A Team at work
  • Point #3: Team members Led by Key Opinion Leader [https://lnkd.in/eEyn69r] generated Intellectual Property (IP) of Three Asset Classes
  • Point #4: Functions and Forms by Asset Class
  • Point #5: SYNERGY among the Three Asset Classes stimulates Value Creation
  • Point #6: Plan for Team membership augmentation and Training under existing Leadership and New Ownership

 

POINT #1: Top Author, Chief Scientific Officer, a retired Chief of Pathology, LHB, MD, FCAP – share in the Journal’s archive computed

Journal archive has 5,486 articles published

LHB has published 1,390 articles = 25.33% – he joined our team with a publication list of +200 articles in referred academic journals. LHB is co-curator of many articles with many of the team members

  • The Young Surgeon and The Retired Pathologist: On Science, Medicine and HealthCare Policy– The Best Writers Among the WRITERS

https://pharmaceuticalintelligence.com/2013/12/10/the-young-surgeon-and-the-retired-pathologist-on-science-medicine-and-healthcare-policy-best-writers-among-the-writers/

 

POINT #2: Top authors by e-Readers per article – A Team at work

Click on this link to review the contributions of Team members who’s articles achieved >1,000 Views.

  • Article Title, Author/Curator’s Name and Article Views >1,000, 4/2012 – 1/2019 @pharmaceuticalintelligence.com

https://pharmaceuticalintelligence.com/2019/01/30/article-title-author-curators-name-and-article-views-1000-4-2012-1-2018-pharmaceuticalintelligence-com/

 

POINT #3: Team members led by Key Opinion Leader (KOL) [https://lnkd.in/eEyn69r] generated Intellectual Property (IP) of Three Asset Classes

 

List of LPBI IP Assets by Asset Class representing a Team Effort

 

  • IP Asset Class I: Launched Open Access Online Scientific Journal @com, 4/2012

https://lnkd.in/erfbayJ

  •  IP Asset Class II: Launched BioMed eSeries, 16-Volumes in Life Sciences and Medicine, 10/2012

BioMed e-Series: 16 Volumes – electronic Table of Contents (eTOCs) of each Volume

https://pharmaceuticalintelligence.com/2017/12/12/biomed-e-series-16-volumes-electronic-table-of-contents-of-each-volume/


Launched 6 Volumes Cardiovascular Diseases e-Series, Bundled on Amazon for $515

https://lnkd.in/e6WkMgF

Launched 10 Volumes in Medicine: Genomics 1,2  Cancer 1,2 Immunology 1,2,3  Precision Medicine 1,2,3,4

https://lnkd.in/ekWGNqA

 

  • IP Asset Class III: Launched Real Time Press Coverage of Biotech Conferences, 3/2013

https://pharmaceuticalintelligence.com/press-coverage/

Part One: The Process of Real Time Coverage using Social Media

Part Two: List of BioTech Conferences 2013 to Present

Part Three: Conference eProceedings DELIVERABLES & Social Media Analytics

 

POINT #4: FUNCTIONS and FORMS by ASSET CLASS

 

LPBI Group’s IP:VENTURE’s Future Potential
IP Asset Class I
https://lnkd.in/erfbayJ
IP Asset Class II
https://lnkd.in/ekWGNqA
IP Asset Class III
https://pharmaceuticalintelligence.com/press-coverage/
Open Access Journal– M1.5 e-Readers,- 5.5K articles- 670 categories,- 7.3K comments- 10K Tags
BioMed E-Series– 16 Volumes- 5 Specialties in Medicine- 6 Volumes Cardiovascular Diseases e-Series, Bundled on Amazon for $515https://lnkd.in/e6WkMgF
Real Time Coverage BioTech/Medicine Conferences– eProceedings- Real Time Tweets on- Two Twitter Handles- Conference Hash Tags@pharma_BI@AVIVA1950- Part Two: List of BioTech Conferences 2013 to Present
Editor-in-Chief’sLeadership:- Senior Editors- Our Team
Our Team’s Product
https://pharmaceuticalintelligence.com/contributors-biographies/
Senior Editors’ Product with Our Team
https://pharmaceuticalintelligence.com/contributors-biographies/senior-editors/https://pharmaceuticalintelligence.com/contributors-biographies/
Editor-in-Chief’s Initiative
https://lnkd.in/eEyn69r
Architecture   Methodologies for ourPlatforms
·       Multi-Authoring Platform – wordpress.com·       Authoring Privilege levels·       Categories of research forming the Journal’s Ontology, a Dynamic Relational and Hierarchical database Multi-Authoring architecture·       Generation of new categories by authors developing the categories they are Owners of·       Article update policy
·       eTOCs design by Editors·       e-Book Style uniformity across all eSeries·       Structure of eBook Parts·       Structure of Chapters·       Structure of Articles·       Commission of Articles Specifically for given e-Books by Editor-in-Chief·       Overarching guidance for e-Books within each eSeries and across eSeries
·       Part One: The Process of Real Time Coverage using Social Media·       Methodology for Conference Coverage using Social Media: 2014 MassBio Annual Meeting 4/3 – 4/4 2014, Royal Sonesta Hotel, Cambridge, MA·       Template Development Process·       Channels of Social Media Development
Business ModelDevelopment: Content Creation by Curation of Scientific Findings
·       Author/Curator initiated article·       Article Commissions by Editor-in-Chief·       Co-Curations·       Research Category Ownership·       e-Books Editors role defined (Job description)
·       e-Books in Kindle Store·       30,000 Oncologists in the US·       40,000 Cardiologists in the US·       All Primary Care Physicians·       All Medical Schools for Curriculum development·       Global market for Medical EducationALL BioMed 16 Volumes [$515+$190+$175+$190+$274 = $1,344]@Amazon BUNDLED 6 Volumes Cardiovascular Diseases for $515https://lnkd.in/e6WkMgF@Amazon UNBUNDLED 10 Volumeshttps://lnkd.in/ekWGNqA·       Genomics 1,2 ($190)·       Cancer 1,2 ($175)·       Metabolomics, Immunology, Infectious Diseases 1,2,3 (#190)·       Precision Medicine 1,2,3,4 ($274)
·       The market is defined as “All Biotech Conferences Organizers around the Globe” in need to own eProceedings for their Conferences for electronic dissemination to conference attendees.·       Digital Archive of Conferences eProceedingsPart Three: Conference eProceedings DELIVERABLES & Social Media Analytics
 
IP Asset Class III
https://pharmaceuticalintelligence.com/press-coverage/
Real Time Coverage BioTech/Medicine Conferences
– eProceedings
– Real Time Tweets on
– Two Twitter Handles
– Conference Hash Tags
@pharma_BI
@AVIVA1950
Part Two: List of BioTech Conferences 2013 to Present
Editor-in-Chief’s Initiative
https://lnkd.in/eEyn69r
·       Part One: The Process of Real Time Coverage using Social Media
·       Methodology for Conference Coverage using Social Media: 2014 MassBio Annual Meeting 4/3 – 4/4 2014, Royal Sonesta Hotel, Cambridge, MA
·       Template Development Process
·       Channels of Social Media Development
·       The market is defined as “All Biotech Conferences Organizers around the Globe” in need to own eProceedings for their Conferences for electronic dissemination to conference attendees.
·       Digital Archive of Conferences eProceedings
Part Three: Conference eProceedings DELIVERABLES & Social Media Analytics

POINT #4 (IN DETAIL): Functions and Forms by Asset Class

 

IP Asset Class I: The Journal

 

The Methodology of Curation for Scientific Research Findings

https://pharmaceuticalintelligence.com/2014/07/30/the-methodology-of-curation-for-scientific-research-findings/

 

>> Evolution of Platform Architecture Methodologies: 

  • Multi-Authoring Platform – wordpress.com
  • Authoring Privilege levels
  • Categories of research forming the Journal’s Ontology, a Dynamic Relational and Hierarchical database Multi-Authoring architecture
  • Generation of new categories by authors developing the categories they are Owners of
  • Article update policy

 

>> Intellectual Property Development (Content Creation by Curation) Business Model 

  • Author/Curator initiated article
  • Article Commissions by Editor-in-Chief
  • Co-Curations
  • Research Category Ownership
  • e-Books Editors role defined (Job description)

 

IP Asset Class II: BioMed e-Series

 

> Evolution of Platform Architecture Methodologies

Cardiovascular Original Research: Cases in Methodology Design for Content Curation and Co-Curation

https://pharmaceuticalintelligence.com/2013/07/29/cardiovascular-original-research-cases-in-methodology-design-for-content-curation-and-co-curation/

  • eTOCs design by Editors
  • e-Book Style uniformity across all eSeries
  • Structure of eBook Parts
  • Structure of Chapters
  • Structure of Articles
  • Commission of Articles Specifically for given e-Books by Editor-in-Chief
  • Overarching guidance for e-Books within each eSeries and across eSeries

 

> Intellectual Property Development (Content Creation by Curation) Business Model 

 

  • e-Books in Kindle Store
  • 30,000 Oncologists in the US
  • 40,000 Cardiologists in the US
  • US & Global markets for Cardiology, Genomics, Cancer, Immunology, Infectious Diseases, Precision Medicine
  • All Primary Care Physicians
  • All Medical Schools for Curriculum development
  • Global market for Medical Education

 

ALL BioMed 16 Volumes [$515+$190+$175+$190+$274 = $1,344]

@Amazon BUNDLED 6 Volumes Cardiovascular Diseases for $515 https://lnkd.in/e6WkMgF

@Amazon UNBUNDLED 10 Volumes in #Medicine https://lnkd.in/ekWGNqA

  • Genomics 1,2 ($190)
  • Cancer 1,2 ($175)
  • Metabolomics, Immunology, Infectious Diseases 1,2,3 (#190)
  • Precision Medicine 1,2,3,4 ($274)

 

Series A – Cardiovascular Diseases – 6 volumes $515

 

Series B – Genomics 1,2  – 2 volumes $190

  • VOLUME 1: Genomics Orientations for Personalized Medicine. On comsince 11/23/2015

http://www.amazon.com/dp/B018DHBUO6

  • VOLUME 2: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS & BioInformatics, Simulations and the Genome Ontology

https://pharmaceuticalintelligence.com/biomed-e-books/genomics-orientations-for-personalized-medicine/volume-two-genomics-methodologies-ngs-bioinformatics-simulations-and-the-genome-ontology/

Volume 2 is Work-in-Progress To Be Published in 6/2019 at $115

 

Series C – Cancer & Oncology $175 

  • VOLUME 1 Cancer Biology Genomics

http://www.amazon.com/dp/B013RVYR2K

  • VOLUME 2 Therapies Genomics Interventional Immunotherapy Nanotechnology in Drug Delivery

http://www.amazon.com/dp/B071VQ6YYK

 

Series D – Metabolomics, Immunology, Infectious Diseases $190

  • VOLUME 1 Metabolomics

http://www.amazon.com/dp/B012BB0ZF0

  • VOLUME 2 Infectious Diseases & VOLUME 3 Immunology

https://www.amazon.com/dp/B075CXHY1B

 

Series E Precision Medicine – Four Volumes, Volumes 1,2,3,4 at $274

  • Patients Voices

https://www.amazon.com/dp/B076HGB6MZ

  • Physiology and Therapeutics

https://www.amazon.com/dp/B078313281

  • Medical Discoveries: Genomics Therapeutics

http://www.amazon.com/dp/B019VH97LU

  • 3D #BioPrinting in Medicine for Precision Medicine

https://www.amazon.com/dp/B078QVDV2W

 

IP Asset Class III: Real Time Coverage of BioTech Conferences

 

>> Evolution of Platform Architecture Methodologies

https://pharmaceuticalintelligence.com/2014/04/07/methodology-for-conference-coverage-using-social-media-2014-massbio-annual-meeting-43-44-2014-royal-sonesta-hotel-cambridge-ma/

  • Template Development Process
  • Channels of Social Media Development

 

>> Intellectual Property Development (Content Creation by Curation) Business Model 

  • The market is defined as “All Biotech Conferences Organizers around the Globe” in need to own eProceedings for their Conferences for electronic dissemination to conference attendees.
  • Digital Archive of Conferences eProceedings

 

POINT #5: SYNERGY among the Three Asset Classes stimulates Value Creation

 

  • Concepts from +60 Conferences I covered yielded ~300 new articles, five new per conference, at least
  • Electronic Table of Contents [eTOCs] for each e-Book of the [1,2,3..,16] is derived from the Research categories of the Journal
  • Journal Ontology has 700 Research Categories – knowledge architecture designed by experts
  • Every article in the Journal is connected with Social Media Icons on wordpress.com as an engine for
  1. Pingbacks
  2. New eReaders
  3. Scientists applying to author for the Journal
  4. +7,300 Scientific comments on 5,486 articles published – AGORA  

Electronic Scientific AGORA: Comment Exchanges by Global Scientists on Articles published in the Open Access Journal @pharmaceuticalintelligence.com – Four Case Studies

https://pharmaceuticalintelligence.com/2018/04/10/electronic-scientific-agora-comment-exchanges-by-global-scientists-on-articles-published-in-the-open-access-journal-pharmaceuticalintelligence-com-four-case-studies/

 

POINT #6: Plan for Team membership augmentation and Training under existing Leadership and New Ownership

Work-in-Progress

 

 

Other related articles published in this Open Access Online Scientific Journal include the following: 

 

Innovations in electronic Scientific Publishing (eSP): Case Studies in Marketing eContent, Curation Methodology, Categories of Research Functions, Interdisciplinary conceptual innovations by Cross Section of Categories, Exposure to Frontiers of Science by Real Time Press coverage of Scientific Conferences

https://pharmaceuticalintelligence.com/2017/05/06/case-studies-of-innovations-in-electronic-scientific-publishing-esp-marketing-econtent-curation-methodology-categories-of-research-functions-interdisciplinary-conceptual-innovations-by-cross-sec/

 

e-Scientific Publishing: The Competitive Advantage of a Powerhouse for Curation of Scientific Findings and Methodology Development for e-Scientific Publishing – LPBI Group, A Case in Point

https://pharmaceuticalintelligence.com/2017/06/20/e-scientific-publishing-the-competitive-advantage-of-a-powerhouse-for-curation-of-scientific-findings-and-methodology-development-for-e-scientific-publishing-lpbi-group-a-case-in-point/

 

The Methodology of Curation for Scientific Research Findings

https://pharmaceuticalintelligence.com/2014/07/30/the-methodology-of-curation-for-scientific-research-findings/

 

@PharmaceuticalIntelligence.com – A Case Study on the LEADER in Curation of Scientific Findings

https://pharmaceuticalintelligence.com/2017/06/29/pharmaceuticalintelligence-com-a-case-study-on-the-leader-in-curation-of-scientific-findings/

 

Curation of Scientific Content @Leaders in Pharmaceutical Business Intelligence (LPBI) Group, Boston

https://pharmaceuticalintelligence.com/2016/08/15/curation-of-scientific-content-leaders-in-pharmaceutical-business-intelligence-lpbi-group-boston/

 

Scientific Curation Fostering Expert Networks and Open Innovation: Lessons from Clive Thompson

https://pharmaceuticalintelligence.com/2014/07/17/scientific-curation-fostering-expert-networks-and-open-innovation-lessons-from-clive-thompson-and-others/

 

Cardiovascular Diseases and Pharmacological Therapy: Curations by Aviva Lev-Ari, PhD, RN, 2006 – 4/2018

https://pharmaceuticalintelligence.com/2014/04/17/cardiovascular-diseases-and-pharmacological-therapy-curations-by-aviva-lev-ari-phd-rn/

 

Methodology for Conference Coverage using Social Media: 2014 MassBio Annual Meeting 4/3 – 4/4 2014, Royal Sonesta Hotel, Cambridge, MA

https://pharmaceuticalintelligence.com/2014/04/07/methodology-for-conference-coverage-using-social-media-2014-massbio-annual-meeting-43-44-2014-royal-sonesta-hotel-cambridge-ma/

 

Cardiovascular Original Research: Cases in Methodology Design for Content Curation and Co-Curation

https://pharmaceuticalintelligence.com/2013/07/29/cardiovascular-original-research-cases-in-methodology-design-for-content-curation-and-co-curation/

 

 

 

 

Read Full Post »

Older Posts »